Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma | Zendy

Jianwei Zhang | Zendy; Yanshuo Cao | Zendy; Panpan Zhang | Zendy; Xiaotian Zhang | Zendy; Jian Li | Zendy; Jun Zhou | Zendy; Xicheng Wang | Zendy; Zhi Peng | Zendy; Yu Sun | Zendy; Jie Li | Zendy; Lin Shen | Zendy; Ming Lu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma

Author(s) -

Jianwei Zhang,

Yanshuo Cao,

Panpan Zhang,

Xiaotian Zhang,

Jian Li,

Jun Zhou,

Xicheng Wang,

Zhi Peng,

Yu Sun,

Jie Li,

Lin Shen,

Ming Lu

Publication year - 2021

Publication title -

neuroendocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.493

H-Index - 101

eISSN - 1423-0194

pISSN - 0028-3835

DOI - 10.1159/000519948

Subject(s) - medicine , carcinoembryonic antigen , gastroenterology , hazard ratio , oncology , univariate analysis , adenocarcinoma , biomarker , regimen , population , neuroendocrine tumors , cancer , multivariate analysis , confidence interval , biochemistry , chemistry , environmental health

Gastroenteropancreatic neuroendocrine carcinoma (GEPNEC) is a major research focus, but the application of biomarkers to guide its prognostication and management is unsatisfying. Clinical values of conventional serum biomarkers, neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA199) warrant scrutiny.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research